Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis

Mycoses

Volumn 57, Issue 3, 2014, Pages 141-146

  Li, Duo ^a   Li, Qingfu ^a   Liu, Chuanxia ^a   Lin, Mei ^a   Li, Xiaoying ^a   Xiao, Xiaoying ^a   Zhu, Zhu ^a   Gong, Qimei ^a   Zhou, Hongmei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Antifungal agents; Candida spp.; Probiotics; Stomatitis

Indexed keywords

NYSTATIN; PROBIOTIC AGENT;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM LONGUM; CANDIDA ALBICANS; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGAL DETECTION; GARGLE; HEADACHE; HUMAN; HYPEREMIA; LACTOBACILLUS BULGARICUS; MAJOR CLINICAL STUDY; MALAISE; MALE; MIDDLE AGED; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS THERMOPHILUS; THRUSH; TREATMENT DURATION; VISUAL ANALOG SCALE; VOMITING; YOUNG ADULT;

ANTIFUNGAL AGENTS; CANDIDA SPP.; PROBIOTICS; STOMATITIS;

AGED; ANTIFUNGAL AGENTS; BIFIDOBACTERIUM; CANDIDA; CANDIDIASIS, ORAL; FEMALE; HUMANS; LACTOBACILLUS; MALE; MIDDLE AGED; NYSTATIN; PROBIOTICS; SODIUM BICARBONATE; STREPTOCOCCUS THERMOPHILUS;

EID: 84893614285     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12116     Document Type: Article

References (36)

1. Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol 2011; 3: 1-11.
2. Akpan A. Oral candidiasis. Postgrad Med J 2002; 78: 455-9.
3. Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology 2010; 98: 15-25.
4. Hamad M. Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections. Scand J Immunol 2008; 67: 533-43.
5. Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J 2004; 80: 516-26.
6. Manzoni P, Mostert M, Leonessa ML et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006; 42: 1735-42.
7. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases update: 2011. J Clin Gastroenterol 2011; 45: S139-44.
8. Martinez RC, Franceschini SA, Patta MC et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 2009; 48: 269-74.
9. Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infec 2007; 13: 657-64.
10. Krasse P, Carlsson B, Dahl C et al. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 2006; 30: 55-60.
11. Shimazaki Y, Shirota T, Uchida K et al. Intake of dairy products and periodontal disease: the Hisayama Study. J Periodontol 2008; 79: 131-7.
12. Ahola AJ, Yli-Knnuuttila H, Suomalainen T et al. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol 2002; 47: 799-804.
13. Matsubara VH, Silva EG, Paula CR et al. Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). Oral Dis 2012; 18: 260-4.
14. Twetman S, Derawi B, Keller M. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand 2009; 67: 19-24.
15. Hatakka K, Ahola AJ, Yli-Knuuttila H et al. Probiotics reduce the prevalence of oral candida in the elderly-a randomized controlled trial. J Dent Res 2007; 86: 125-30.
16. Strus M, Kucharska A, Kukla G et al. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 2005; 13: 69-75.
17. Shanahan F. A commentary on the safety of probiotics. Gastroenterol Clin North Am 2012; 41: 869-76.
18. Borriello SP, Hammes WP, Holzapfel W et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36: 775-80.
19. Maukonen J, Ma J, Suihko M et al. Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol 2008; 57: 1560-8.
20. Tollemar J, Gross N, Dolgiras N et al. Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients. Bone Marrow Transpl 1999; 23: 283-90.
21. Groeschke J, Solassol I, Bressolle F et al. Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate. J Pharm Biomed Anal 2006; 42: 362-6.
22. Sousa FA, Paradella TC, Koga-Ito CY et al. Effect of sodium bicarbonate on Candida albicans adherence to thermally activated acrylic resin. Braz Oral Res 2009; 23: 381-5.
23. Williams DW, Kuriyama T, Silva S et al. Candida biofilms and oral candidosis: treatment and prevention. Periodontol 2000 2011; 55: 250-65.
24. Golomb BA, Erickson LC, Koperski S et al. What's in placebos: who knows? Analysis of randomized, controlled trials. Ann Intern Med 2010; 153: 532-5.
25. Boukraâ L, Bouchegrane S. Additive action of honey and starch against Candida albicans and Aspergillus niger. Rev Iberoam Micol 2007; 24: 309-11.
26. Klein MI, Duarte S, Xiao J et al. Structural and molecular basis of the role of starch and sucrose in Streptococcus mutans biofilm development. Appl Environ Microbiol 2009; 75: 837-41.
27. Allaker RP, Waite RD, Hickling J et al. Topographic distribution of bacteria associated with oral malodour on the tongue. Arch Oral Biol 2008; 53(Suppl. 1): S8-12.
28. Yucesoy M. Comparison of three differential media for the presumptive identification of yeasts. Clin Microbiol Infect 2005; 11: 245-7.
29. Peran L, Camuesco D, Comalada M et al. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroentero 2005; 11: 5185-92.
30. Kumar S, Singhi S. Role of probiotics in prevention of Candida infection in critically ill children. Mycoses 2013; 56: 204-11.
31. Cannon RD, Lyons KM, Chong K et al. Adhesion of yeast and bacteria to oral surfaces. Methods Mol Biol 2010; 666: 103-24.
32. Nakamura T, Hirai K, Shibata Y et al. Purification and properties of a bacteriocin of Staphylococcus epidermidis isolated from dental plaque. Oral Microbiol Immunol 1998; 13: 387-9.
33. Shirtliff ME, Peters BM, Jabra-Rizk MA. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett 2009; 299: 1-8.
34. Li X, Kolltveit KM, Tronstad L et al. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000; 13: 547-58.
35. Africa CW. Oral colonization of Gram-negative anaerobes as a risk factor for preterm delivery. Virulence 2011; 2: 498-508.
36. Köstler WJ, Hejna M, Wenzel C et al. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001; 51: 290-315.